| Bioactivity | (S)-DOTAGA.(SA.FAPi)2 is a precursor for radiopharmaceutical labeling, which can be combined with radionuclides to create radionuclide drug conjugates (RDCs). RDCs have the capability to specifically target biomolecules and can be used in medical imaging or therapy[1]. |
| CAS | 2417089-06-4 |
| Formula | C71H83F4N17O17 |
| Molar Mass | 1522.52 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Frank Rösch, et al. Marking precursor with square acid coupling. DE102018126558A1. 2020 April 30. |
(S)-DOTAGA.(SA.FAPi)2
CAS: 2417089-06-4 F: C71H83F4N17O17 W: 1522.52
(S)-DOTAGA.(SA.FAPi)2 is a precursor for radiopharmaceutical labeling, which can be combined with radionuclides to creat
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.